新华制药

- 000756

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
新华制药(000756) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入247,469.75810,084.47649,753.48467,226.90263,966.58
营业收入247,469.75810,084.47649,753.48467,226.90263,966.58
二、营业总成本232,892.90753,090.48603,925.78431,175.04246,014.20
营业成本179,572.97570,914.24460,740.77328,104.63181,132.31
营业税金及附加1,843.499,217.537,860.416,047.664,205.56
销售费用29,106.4078,017.1464,344.6948,703.8935,290.20
管理费用7,884.0051,382.4835,915.6224,631.6712,617.44
财务费用295.461,635.13936.11134.201,556.73
研发费用14,190.5841,923.9734,128.1923,552.9911,211.96
资产减值损失----------
公允价值变动收益----------
投资收益118.87958.34968.90828.647.80
其中:对联营企业和合营企业的投资收益118.87141.76152.3312.067.80
汇兑收益----------
三、营业利润17,055.7053,458.2044,687.0233,395.6318,579.81
加:营业外收入19.38553.71419.3763.2035.98
减:营业外支出197.93743.34458.71264.25123.85
其中:非流动资产处置损失----------
四、利润总额16,877.1553,268.5744,647.6833,194.5818,491.93
减:所得税费用2,350.742,657.874,618.705,626.543,090.89
五、净利润14,526.4150,610.7040,028.9827,568.0415,401.04
归属于母公司所有者的净利润14,187.9449,651.2239,196.8426,980.7215,160.38
少数股东损益338.47959.48832.14587.33240.66
六、每股收益
基本每股收益(元/股)0.21000.74000.58000.40000.2300
稀释每股收益(元/股)0.21000.72000.57000.39000.2200
七、其他综合收益81.53173.602,431.771,387.30770.98
八、综合收益总额14,607.9450,784.3042,460.7528,955.3416,172.02
归属于母公司所有者的综合收益总额14,268.6849,800.3541,583.9228,315.4115,949.46
归属于少数股东的综合收益总额339.26983.96876.83639.93222.56
下载全部历史数据到excel中 返回页顶